Skyrizi 600 mg concentrate for solution for infusion | medicines.ie

Company: AbbVie Limited
Active Ingredient: Risankizumab
Strength: Risankizumab: 600 mg
Dosage Form: Solution for infusion
Legal Category: A - prescription, may not be renewed
Last Updated: 25/09/2026

Loading the document

AbbVie Limited

Citywest Business Campus, Dublin 24, Ireland